Skip to the guide Care, decoded Questions behind doctor-led peptide care Check a licence Your pathway In this guide What peptide care means Medicine & the rules Read the evidence Find and check care What a visit involves Work out the cost Know when to pause Start at the beginning, or go to the question on your mind. A plain-language guide, not a clinic # Doctor-led peptide clinic: know the route. Before choosing a service, know what the medicine is, who makes the decision and what the full plan costs. Start with the basics The care pathway Your health concern A real assessment A care plan No medicine A prescription is a possible outcome. Start with the assessment. U.S. rules and prices, as of September 2026. Go to costs ## Understand the medicine before the offer Start with the basics ### What peptide care means #### Start with the word “peptide” A peptide links protein building blocks into a short chain. Insulin is one example. Seeing “peptide” on a product tells you neither its safety nor its legal status. #### “Doctor-led” is a claim to check Ask who will assess you, who decides on treatment and who answers when you have questions. A doctor’s name in a website header does not answer those questions. Begin by naming the health problem you need help with. Then ask which options fit it, including options that do not involve a medicine. The starting point Bring a health problem to an assessment. Leave room for the answer to change the plan. #### Is peptide care real? The exact product matters. As of September 2026, different rules apply to approved medicines, medicines made to order by a pharmacy and chemicals labelled for lab experiments rather than treatment. Get the medicine’s complete name, along with its form: pill, shot or something else. A broad label like “peptide therapy” leaves too much unanswered. Know what is being proposed ### Medicine and the rules #### Approved products have a named use FDA stands for Food and Drug Administration. This U.S. agency reviews medicines. An FDA approval covers one named product for a particular use. FDA approval explained Semaglutide and tirzepatide are medicine ingredients used in products for type 2 diabetes or weight management. Type 2 diabetes is a condition that affects how the body controls blood sugar. As of September 2026, approved semaglutide products include Ozempic, used for type 2 diabetes, and Wegovy, used for weight management. For tirzepatide, the approved products are Mounjaro to treat type 2 diabetes and Zepbound for weight management. FDA approval records Ask which approved use applies to your health concern. #### Compounding meets a different need Compounding involves making or changing a medicine for an individual patient rather than supplying a drug company’s ready-made product. The FDA says it may meet a need an approved product cannot, such as leaving out an ingredient a patient is allergic to. FDA compounding guide As of September 2026, medicines prepared through compounding have no FDA approval. The FDA does not review compounded medicines for safety, quality or how well they work before they are sold. FDA on compounded drugs As of September 2026, U.S. law allows compounding within rules for the maker, the ingredients and the type of medicine. It does not allow every ingredient. An ordinary pharmacy’s rules, as of September 2026, include a licensed pharmacist or doctor and a valid prescription that identifies the patient. The raw ingredient must meet official drug-quality standards if those exist. Under rules current as of September 2026, an ingredient without those standards must be used in an approved drug or included on the FDA’s list of permitted ingredients. These are part of the rules the pharmacy must meet. Ask it to explain why the exact medicine it offers is allowed, and check its licence using the steps below. #### A research label does not mean treatment BPC-157, ipamorelin and retatrutide are peptide names you may see in an offer. As of September 2026, none has an FDA-approved U.S. medicine for any health problem. FDA product records Cagrilintide is another peptide with no FDA-approved use, as of September 2026. The FDA also says federal law does not allow pharmacies to make medicines from retatrutide or cagrilintide. FDA on these ingredients If one of these names appears in an offer for your health problem, ask: “What are you proposing it would treat, and what evidence supports that use?” In letters reviewed as of September 2026, the FDA warned that a “research use only” label does not excuse marketing unapproved drugs for people. FDA enforcement letter #### If weight loss is the reason for your search GLP-1 is a hormone that signals within the body to help control blood sugar and appetite. Medicines such as semaglutide and tirzepatide are often called GLP-1 drugs. In the FDA’s national shortage records, neither semaglutide injections nor tirzepatide is listed as in short supply, as of September 2026. FDA shortage update A national shortage had allowed pharmacies to make copies of those medicines. As of September 2026, they can no longer rely on that shortage to make copies. A pharmacy may still be able to make a changed version for one patient, under rules current as of September 2026. The person prescribing it must judge that the alteration has a meaningful effect on that patient’s medical need. Ask: “What change do I need, and why can’t an approved product meet that need?” A price reduction alone cannot qualify as that important difference. Adding a vitamin does not, by itself, put a medicine outside the rules for copies. FDA copy rules Make evidence part of the conversation ### What the evidence can tell you #### Match the evidence to the exact product Ask what supports the proposed medicine for your health problem. Is it an approved use, a pharmacy-made version or a product still being studied? FDA guidance current as of September 2026 calls it misleading to say studies in people prove a compounded medicine matches an approved product’s results. FDA evidence-claim guidance Ask: “What did studies in people find about this exact medicine for my health problem?” Ask what remains unknown. #### A report of a problem does not prove the medicine caused it The FDA explains that reporting a problem does not establish the medicine as its cause. Those reports also cannot tell you how often a problem occurs. FDA report limitations That makes a useful question for the visit: how does the evidence fit my own health history? ## Put names and a visit behind the offer Put names behind the claims ### How to find and check care #### Choose the kind of visit you need An in-person medical practice or a licensed telehealth service serving your state is a place to ask about an assessment. Describe the health concern you want help with. Ask whether you will see a doctor and what “doctor-led” means there. If another health professional will assess you, ask their job title and which board holds their licence. #### Open the doctor’s licence record Doctors receive their licences from state medical boards, which also publish the licence records. These can show penalties the board has imposed and formal charges still awaiting a decision. What it publishes varies by state. Medical boards’ public records Use the directory published by the Federation of State Medical Boards to find your state’s board. Then search for the doctor’s full name. Find your state medical board Confirm the licence is current, then look for any board-imposed limits or penalties. Ask the board to explain any entry you do not understand. This search checks the doctor’s licence and any public penalties; it does not rate how good the care is. #### Check the medicine’s source separately Ask for the pharmacy’s name before agreeing to a plan. Find out who will make or supply the medicine, even if the service puts its own name on the package. The FDA’s state pharmacy search leads to the board that holds the licence record. Find the pharmacy licence search If the pharmacy is missing from that state’s records, the FDA advises against using it. “FDA registered” does not mean that a pharmacy or its medicine has FDA approval, as of September 2026. FDA on registration and approval A question that gets to the point Who will make the medicine, and where can I check their licence? Picture the visit ### What getting care involves #### Choose a kind of visit you can use Telehealth is care at a distance: by video, phone or an online exchange. At an in-person visit, you meet the person assessing you in the same room. That may be a doctor or another health professional; ask their job title before booking. An online visit may start with forms and move to a conversation. Ask whether the visit uses video, phone or written questions. State rules for writing prescriptions during online or phone visits differ, as of September 2026. HHS is the U.S. health department. Its guidance, checked in September 2026, requires a licence or legal permission for the person treating you. That permission must apply in the state where you are physically located during your visit. HHS licence guidance Some states let a doctor licensed elsewhere register to provide online care there, as of September 2026. Tell the service your planned location for the call, naming the state. Ask that state’s medical board to check the doctor’s licence or registration for online care. #### Bring your health history to the visit Write down what you want help with, your medicines and supplements, allergies and past treatment. Keep any records you want to discuss close by. Tell the person assessing you if you are pregnant, breastfeeding or planning a pregnancy. Ask how that affects the proposed care. #### An assessment can change the plan The Federation of State Medical Boards is made up of state medical licensing boards. In guidance current as of September 2026, the group says treatment cannot be based solely on an online questionnaire whose questions and answers remain fixed. The person conducting your assessment must be able to raise further questions as needed. The guidance also calls for you to be able to ask the person providing care your own follow-up questions. Medical boards’ guidance If you need tests or an in-person examination for the assessment, the group’s telehealth policy calls on the doctor to arrange that care or refer you to someone able to provide it. Medical boards’ telehealth policy Ask what could make the answer “no medicine” and what else could help. The goal is an explained decision you can understand. #### Set up follow-up before paying The FDA warns against services where, once medicine arrives, a licensed doctor cannot be reached with questions. FDA telehealth checks Ask who handles questions, when the plan is reviewed and how care continues if the service cannot help. Get those answers before agreeing to the plan. Ask for the whole bill ## What you may pay ### Separate care fees from medicine costs Get the first month’s total in writing, plus the usual monthly total once an offer is over. Does the headline price include medicine or only access to the service? Ask about visits, membership, tests and delivery. Find out what is still charged if no medicine is prescribed, and how to cancel. The total to ask for Care fees Medicine Any tests Delivery Ask which parts apply to the plan. ### A cash-price example, with the limits attached As of September 2026, the government’s Ozempic page lists an offer of $199 per month for new patients paying outside insurance. Its terms require U.S. residence and age 18 or older. Government price page The offer covers only the first two monthly supplies and ends December 31, 2026. Strength means the amount of medicine in the product. Only the two lower strengths listed on that page qualify for the $199 offer. Ask the pharmacy whether the strength on your prescription qualifies. If you already take Ozempic or have used a cash offer before, ask whether you count as a new patient before relying on this price. Later prices on that page are $349 or $499 per month, depending on strength. Self-pay means paying outside insurance. This medicine price leaves a separate question: what does the care service charge? ### Get an insurance answer for the exact product Ask your insurer about the product and the reason it is prescribed. Prior authorization is the insurance plan’s advance approval for coverage. Even if a medicine qualifies for coverage, payment by your plan is not assured. ### Medicare has a separate temporary program As of September 2026, medicines taken solely for weight loss remain excluded from Medicare’s Part D drug benefit. Part D can cover a medicine used for type 2 diabetes rather than weight loss, subject to the plan’s requirements. Medicare is run by CMS, which offers the Medicare GLP-1 Bridge as a separate, temporary program. As of September 2026, eligible people pay a $50 monthly copay through the Bridge for certain medicines. A copay is your share of the bill. CMS Bridge program The program runs from July 1, 2026 through December 31, 2027. #### Who can use the Bridge As of September 2026, the Bridge’s age requirement is 18 or older; age 80 alone does not exclude you. Weight, health conditions and the type of Medicare drug plan also affect whether you qualify. CMS eligibility details A prescription and advance approval are required. Ask your doctor to check the program’s weight and health-condition rules and whether your plan qualifies. Receiving a GLP-1 medicine through Part D during 2026 makes you ineligible for the Bridge that year. People with type 2 diabetes use the regular Part D benefit instead of the Bridge. #### How the Bridge payment counts The Bridge’s $50 monthly payment is separate from ordinary Part D spending. That payment does not go toward the yearly Part D cap on your own spending. CMS payment limits Reaching that Part D limit does not end the Bridge’s $50 monthly payment. The Bridge does not reduce that payment for people on low incomes. Read the rules for who qualifies with your doctor before counting on this program’s price. ### An offer needs an end-date check For many cash offers and savings cards, the terms expire on December 31, 2026, according to the September 2026 price check. Ask what happens after an offer ends and what the next refill costs. Keep the answer with the written total. Slow down when answers are missing ## When to pause and get help ### Prescription medicine needs a prescription Under federal law as of September 2026, supplying a prescription medicine requires a valid prescription first. FDA guidance warns about medicine sent without a licensed doctor first checking your health and writing a prescription. FDA consumer guidance Ask what that health check includes for you: a conversation, an examination or tests. The visit chapter explains when the medical boards’ guidance calls for tests or an examination. ### “The same as approved” needs checking FDA guidance current as of September 2026 calls it misleading to describe a compounded medicine as the same as an approved one. It also rejects the term “generic” for a compounded medicine. A generic is a brand-name medicine’s approved copy. FDA on misleading claims Ask what the product actually is and which evidence supports it. A confident claim is not the answer to either question. ### Get clear instructions from the pharmacist As of September 2026, the FDA has received reports of hospital care after possible mistakes with the amount of compounded semaglutide used. FDA dosing-error alert Ask for a walk-through of the supplied product’s written instructions and a contact for questions. Bring any unclear wording to the person who wrote your prescription or to the pharmacist. #### Storage instructions for the supplied product How to store a medicine depends on the exact product. For an approved medicine, follow its label. For a pharmacy-made medicine, ask the pharmacy for written storage instructions for the product it supplies. ### Urgent help for a severe allergic reaction MedlinePlus is the health resource of the U.S. National Library of Medicine, and it calls severe allergic reactions life-threatening emergencies. MedlinePlus says to call 911 or go to the emergency room for severe symptoms such as a swollen face or tongue or difficulty breathing. MedlinePlus emergency advice ### Reporting a medicine problem Problems with a medicine can also be reported to MedWatch, the FDA’s reporting service for patients and health professionals. FDA MedWatch Making a report is separate from getting care. Ready for the next conversation A clear plan starts with clear answers. Ask for an explanation you can repeat in your own words. Cover the health goal, the medicine, the evidence, the follow-up and the full cost. Return to the licence checks Use this guide to understand peptide care. This site neither provides clinical care nor sells treatment. Read as text Full text file Back to top